22
Participants
Start Date
October 31, 2012
Primary Completion Date
September 30, 2016
Study Completion Date
September 30, 2016
Avastin in combination with Roferon-A
Afinitor
TKI: Sutent, Nexavar or Votrient
TKI
Charité Berlin, Berlin
University Hospital Bonn, Bonn
University Hospital Dresden, Dresden
University Hospital Düsseldorf, Düsseldorf
Waldkrankenhaus St. Marien, Erlangen
University Hospital Essen, Essen
University Hospital Frankfurt, Frankfurt
University Hospital Freiburg, Freiburg im Breisgau
University Hospital Göttingen, Göttingen
Oncological Practice Hannover, Hanover
University Hospital Hannover, Hanover
University Hospital Magdeburg, Magdeburg
University Hospital Tübingen, Tübingen
Central European Society for Anticancer Drug Research
OTHER